ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

ACS Forms Foundation To Handle Large Gifts

September 4, 1992

Human Subject Rules Now Have forces Of Law; Already Conforming

June 7, 1974

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978